120973-72-0

Basic information

• Product Name: 2-benzoylbenzofuran-5-carbaldehyde
• Synonyms: 2-benzoylbenzofuran-5-carbaldehyde
• CAS NO: 120973-72-0
• Molecular Weight: 250.254
• Mol File: 120973-72-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-benzoylbenzofuran-5-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-benzoylbenzofuran-5-carbaldehyde(120973-72-0)
• EPA Substance Registry System: 2-benzoylbenzofuran-5-carbaldehyde(120973-72-0)

Safety Data

• Hazardous Substances Data: 120973-72-0(Hazardous Substances Data)

Upstream product

• 194471-24-4 5-bromomethyl-2-benzofuranyl phenyl ketone 
• 123-08-0 4-hydroxy-benzaldehyde 
• 613-84-3 2-hydroxy-5-methylbenzaldehyde 
• 101277-97-8 (5-methylbenzofuran-2-yl)(phenyl)methanone 
• 194471-26-6 5-hydroxymethyl-2-benzofuranyl phenyl ketone 
• 3328-70-9 5-formyl-2-hydroxybenzaldehyde 
• 70-11-1 α-bromoacetophenone 

Downstream Products

• 1416512-15-6 3-(2-benzoyl-benzofuran-5-yl)-1-[5-hydroxy-2-methyl-2-(4-methyl-pent-3-enyl)-2H-chromen-6-yl]-propenone 
• 951656-27-2 trans-3-(2-benzoylbenzofuran-5-yl)-N-(tetrahydropyran-2-yloxy)acrylamide 
• 951656-24-9 trans-3-(2-benzoylbenzofuran-5-yl)acrylic acid 
• 951656-21-6 trans-3-(2-benzoylbenzofuran-5-yl)acrylic acid tert-butyl ester 

Relevant articles and documents

2-Aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors

Histone deacetylase (HDAC) inhibitors are considered to be drugs for targeted cancer therapy and second-generation HDIs are currently being tested in clinical trials. Here, we report on the synthesis and biological evaluation of a novel HDAC inhibitor sca

5-Formyl salicylaldehyde as a linker for the synthesis of benzofuran containing insulin sensitivity enhancer compounds

5-Formyl salicylaldehyde was prepared by treatment of 4-hydroxybenzaldehyde with HMTA in TFA. Reaction of this dialdehyde with α-haloacetyl aryl compounds gave 2,5-disubstituted benzofurans, from which an Insulin Sensitivity Enhancer compound was prepared.